[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346166-105":59,"doc-detail-346166-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","conserved-mirna-regulators-of-pd-1pd-l1-in-glioblastoma-and-colorectal-cancer","Conserved miRNA regulators of PD-1/PD-L1 in glioblastoma and colorectal cancer","","Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis have changed cancer therapy, yet their performance remains limited in glioblastoma (GBM) and inconsistent in colorectal cancer (CRC). MicroRNAs (miRNAs) regulate gene expression post-transcriptionally, including immune checkpoint molecules, but conserved regulatory miRNA networks across these cancers were unclear. Five conserved miRNAs (miR-106a-5p, miR-106b-5p, miR-20a-5p, miR-20b-5p, miR-138-5p) were consistently dysregulated in GBM and CRC, linked to survival and inverse checkpoint gene relationships. Pathway enrichment highlighted TGF-β, Hippo, FoxO and cell cycle signaling, supporting their roles in immune evasion and biomarker potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/conserved-mirna-regulators-of-pd-1pd-l1-in-glioblastoma-and-colorectal-cancer/346166/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/conserved-mirna-regulators-of-pd-1pd-l1-in-glioblastoma-and-colorectal-cancer/346166.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which miRNAs were identified as conserved and consistently dysregulated in both glioblastoma and colorectal cancer?","Question",{"text":112,"@type":113},"Five conserved miRNAs—miR-106a-5p, miR-106b-5p, miR-20a-5p, miR-20b-5p, and miR-138-5p—met selection criteria and were consistently dysregulated in both cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are the identified miRNAs associated with prognosis and survival?",{"text":117,"@type":113},"miR-106a-5p and miR-106b-5p were upregulated in both cancers and correlated with improved survival. miR-20a-5p and miR-20b-5p related to favourable outcomes, particularly in MSS CRC, while miR-138-5p showed downregulation in tumors but an opposite survival association, where higher levels linked to worse prognosis.",{"name":119,"@type":110,"acceptedAnswer":120},"What relationship did the study find between miRNA expression and PD-1/PD-L1 pathway gene expression?",{"text":121,"@type":113},"Correlation analysis showed significant inverse associations between several miRNAs and checkpoint gene expression, including examples such as CD274–miR-106a-5p in GBM, CD274–miR-20a-5p in CRC, and PDCD1LG2–miR-20a-5p across both cancers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346166,1790104067,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","RESEARCH ARTICLE     \nConserved miRNA regulators of PD-1/PD-L1 in glioblastoma and colorectal cancer  \nAlja Zottel a,b, Maša Ždralević c,d, Janja Rašoviće, Andrijana Radovićd and Ivana Jovčevska a  \naCenter for Functional Genomics and Biochips, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia; bCenter for Human Molecular Genetics & Pharmacogenomics, Faculty of Medicine, University of Maribor, Maribor, Slovenia; cCenter for Biomedicine, Institute for Advanced Studies, University of Montenegro, Podgorica, Montenegro; dFaculty of Medicine, University of Montenegro, Podgorica, Montenegro; eCenter for Pathology, Clinical Center of Montenegro, Podgorica, Montenegro  \nABSTRACT  \nImmune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis have transformed cancer therapy, but their efficacy remains limited in glioblastoma (GBM) and heterogeneous in colorectal cancer (CRC) . MicroRNAs (miRNAs) regulate gene expression at the post-transcriptional level, including immune checkpoint molecules, yet conserved regulatory miRNA networks across distinct cancers remain poorly defined. Five conserved miRNAs (miR-106a-5p, miR-106b-5p, miR-20a-5p, miR-20b-5p, miR- 138-5p) fulfilled the selection criteria and were consistently dysregulated in GBMand CRC. MiR-106a-5p and miR-106b-5p were upregulated in both cancers and showed favourable prognostic associations, with higher expression correlating with improved survival. miR-20a-5p and miR-20b-5p were preferentially expressed in microsatellite-stable (MSS) CRC and correlated with favourable outcomes in both cancers, whereas miR-138-5p was downregulated in both tumours compared to normal tissue, but showed opposite survival associations, with higher levels linked to worse prognosis. Correlation analysis revealed significant inverse associations between several miRNAs and checkpoint gene expression, including moderate inverse correlations for CD274–miR-106a-5p in GBM, CD274–miR-20a-5p in CRC and PDCD1LG2–miR-20a-5p in both cancers. Pan-cancer profiling demonstrated broad and heterogeneous dysregulation, with expression absent in ovarian cancer for four of the five miRNAs. Pathway enrichment implicated the TGF-β, Hippo, FoxO, and cell cycle pathways, consistent with their known roles in tumour immune evasion. We identified a conserved set of miRNAs that are dysregulated in both GBM and CRC, correlate with survival, and display inverse relationships with PD-1/ PD-L1/PD-L2 expression. These miRNAs represent candidate regulators of the PD-1/ PD-L1/PD-L2 axis and potential biomarkers of tumour biology that may influence immune checkpoint signalling.  \nARTICLE HISTORY  \nRevised 13 June 2026 Accepted 22 June 2026  \nKEYWORDS  \nmicroRNA; posttranscriptional regulation; immune checkpoint; pancancer; biomarker; immunotherapy; immune checkpoint regulation  \nCONTACT Alja Zottel  [alja.zottel@um.si](alja.zottel@um.si)  Centre for Human Molecular Genetics and Pharmacogenomics, Faculty of Medicine, University of Maribor, Taborska Ulica 8, 2000 Maribor, Slovenia  \n© 2026 The Author(s) . Published by Informa UK Limited, trading as Taylor & Francis Group.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ([http://creativecommons.org/licenses/by-nc/4](http://creativecommons.org/licenses/by-nc/4) . 0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.  \n2  A. ZOTTEL ET AL.  \n1. Background  \nImmunotherapy has revolutionized clinical oncology and has brought substantial success in several cancers, such as melanoma, lung cancer, and renal-cell carcinoma [ 1–3]. The most common immunotherapy agents are immune-checkpoint inhibitors (ICIs), which restore","cbCaijtTJC6Ju4Ju","https://ap.wps.com/l/cbCaijtTJC6Ju4Ju","pdf",9291127,21,"English","# Background\n## Immune checkpoint inhibitors and resistance in GBM/CRC\n## miRNAs as post-transcriptional regulators","[{\"question\":\"Which miRNAs were identified as conserved and consistently dysregulated in both glioblastoma and colorectal cancer?\",\"answer\":\"Five conserved miRNAs—miR-106a-5p, miR-106b-5p, miR-20a-5p, miR-20b-5p, and miR-138-5p—met selection criteria and were consistently dysregulated in both cancers.\"},{\"question\":\"How are the identified miRNAs associated with prognosis and survival?\",\"answer\":\"miR-106a-5p and miR-106b-5p were upregulated in both cancers and correlated with improved survival. miR-20a-5p and miR-20b-5p related to favourable outcomes, particularly in MSS CRC, while miR-138-5p showed downregulation in tumors but an opposite survival association, where higher levels linked to worse prognosis.\"},{\"question\":\"What relationship did the study find between miRNA expression and PD-1/PD-L1 pathway gene expression?\",\"answer\":\"Correlation analysis showed significant inverse associations between several miRNAs and checkpoint gene expression, including examples such as CD274–miR-106a-5p in GBM, CD274–miR-20a-5p in CRC, and PDCD1LG2–miR-20a-5p across both cancers.\"}]","Conserved miRNA regulators of PD-1/PD-L1 in glioblastoma and colorectal cancer | PDF",1790060359,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96a740a5f9562b2e962db0eb3cac50f8.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5312decfa5f21a245ce08656a87d1025.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e4fdd2bb7e938ee5fda9202a019b3b75.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d19009b4d7424262296a9261ba82099e.webp",980,1306]